Company Name	Universal Biosensors, Inc.
Ownership Structure	US company listed on ASX
Registered Office in Australia	1 Corporate Avenue Rowville Victoria 3178 Australia
Principal Place of Business	1 Corporate Avenue Rowville Victoria 3178 Australia
Sector	Life Science / Medical Equipment
GICS Industry Group	Health Care Equipment & Services
Internet Homepage Address (URL)	http://www.universalbiosensors.com
Phone Number	+61 3 9213 9000
Fax Number	+61 3 9213 9099
Email Address	info@universalbiosensors.com
Financial Year End	December 31
Board of Directors	Mr Andrew Denver (Chairman) Mr Paul Wright (Chief Executive Officer) Dr Colin Adam (Non-Executive Director) Mr Denis Hanley (Non-Executive Director) Mr Andrew Jane (Non-Executive Director) Mr Marshall Heinberg (Non-Executive Director) [Appointed on 11 January 2010] Dr Jane Wilson (Non-Executive Director) Mr Mark Morrisson [Retired on 9 September 2010]
Management Team	Mr Paul Wright (Chief Executive Officer) [Effective 1 March 2011] Dr Alastair Hodges (Chief Scientist) Mr Salesh Balak (Chief Financial Officer) Mr Garry Chambers (Vice President of Operations) Dr Adrian Oates (Vice President Quality and Regulatory) Dr Fred Davis (Vice President Business Development) Mr Cameron Billingsley (Company Secretary) Mr Mark Morrisson [Retired on 9 September 2010]
Investor Relations Contact	Mr Andrew Denver (Executive Chairman and Interim CEO) Mr Salesh Balak (Chief Financial Officer)
Company Secretary	Mr Cameron Billingsly
Auditor	PricewaterhouseCoopers Freshwater Place Level 19, 2 Southbank Boulevard Southbank VIC 3006 Australia
Solicitors	Australian Legal Adviser PFM Legal Pty Ltd Level 12 117 York Street Sydney NSW 2000 Australia US Legal Adviser Venable LLP 575 7th Street, NW Washington DC 20004 United States of America US Patent Attorneys Davis Wright Tremaine LLP 505 Montgomery Street, Suite 800 San Francisco, CA 94111 United States of America Australian Patent Attorneys Griffith Hack 509 St Kilda Road Melbourne VIC 3004 Australia
Share Registry	Registries Limited Level 2 28 Margaret Street Sydney NSW 2000 Australia
ASX Stock Code	UBI
Listing Date	13 December 2006
Share Capital Information	Total number of shares on issue 159,146,213 (as at 7 May 2012) Total number of options on issue 11,414,290 (as at 7 May 2012) Restricted shares 40,670 (as at 12 May 2010) Shares available to be traded 157,260,841 (as at 12 May 2010)
Top 5 Shareholders	The Principals Cornerstone Fund Pty Ltd 11.7% CM Capital Investments Pty Ltd 11.2% HSBC Custody Nominees (Australia) Ltd 9.4% PFM Cornerstone Ltd 7.5% Cogent Nominees Pty Ltd 5.3% (as at 1 March 2012)
Market Capitalisation	~A$110 million (as at 7 May 2012) ~A$116 million (as at 26 March 2012) ~A$143 million (as at 4 November 2011) ~A$215 million (as at 31 March 2011) ~A$208 million (as at 18 March 2011) ~A$257 million (as at 3 December 2010) ~A$252 million (as at 17 March 2010)
Cash	~A$15.7 million (as at 31 Mar 2012)
Equity Raised since Inception	~A$71 million (as at 7 May 2012)
ABN	121 559 993